Free Trial
LON:OPTI

OptiBiotix Health (OPTI) Share Price, News & Analysis

OptiBiotix Health logo
GBX 11.14 +0.14 (+1.27%)
As of 07/11/2025 10:48 AM Eastern

About OptiBiotix Health Stock (LON:OPTI)

Key Stats

Today's Range
11
11.14
50-Day Range
10.70
20.78
52-Week Range
10
35
Volume
50,421 shs
Average Volume
290,930 shs
Market Capitalization
£10.91 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive OPTI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for OptiBiotix Health and its competitors with MarketBeat's FREE daily newsletter.

OPTI Stock News Headlines

Elon’s BIGGEST warning yet?
Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.
OptiBiotix Health Share Chat (OPTI)
Optibiotix Health PLC (OPTIO)
OptiBiotix Health Plc (OB3.SG)
See More Headlines

OPTI Stock Analysis - Frequently Asked Questions

OptiBiotix Health's stock was trading at GBX 18.05 at the start of the year. Since then, OPTI shares have decreased by 38.3% and is now trading at GBX 11.14.

OptiBiotix Health Plc (LON:OPTI) announced its quarterly earnings results on Monday, June, 30th. The company reported ($1.84) earnings per share for the quarter. OptiBiotix Health had a negative net margin of 524.43% and a negative trailing twelve-month return on equity of 36.76%.

Shares of OPTI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that OptiBiotix Health investors own include SkinBioTherapeutics (SBTX), IQE (IQE), Oracle (ORCL), Digital Globe Services (DGS), Derwent London (DLN), Petrofac (PFC) and IP Group (IPO).

Company Calendar

Last Earnings
6/30/2025
Today
7/12/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Biotechnology
Sub-Industry
Pharmaceutical Products
Current Symbol
LON:OPTI
Previous Symbol
LON:CMI
CIK
N/A
Fax
N/A
Employees
1
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (3.16)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£3.09 million
Net Margins
-524.43%
Pretax Margin
N/A
Return on Equity
-36.76%
Return on Assets
-13.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
6.18
Quick Ratio
7.89

Sales & Book Value

Annual Sales
£590.01 thousand
Price / Sales
18.49
Cash Flow
GBX 1.28 per share
Price / Cash Flow
8.68
Book Value
GBX 7.80 per share
Price / Book
1.43

Miscellaneous

Outstanding Shares
97,943,197
Free Float
N/A
Market Cap
£10.91 million
Optionable
Not Optionable
Beta
1.71
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

This page (LON:OPTI) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners